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Abstract
Background: Motif enrichment analysis of transcription factor ChIP-seq data can help identify transcription factors
that cooperate or compete. Previously, little attention has been given to comparativemotif enrichment analysis of
pairs of ChIP-seq experiments, where the binding of the same transcription factor is assayed under different
conditions. Such comparative analysis could potentially identify the distinct regulatory partners/competitors of the
assayed transcription factor under different conditions or at different stages of development.
Results: We describe a new methodology for identifying sequence motifs that are differentially enriched in one set of
DNA or RNA sequences relative to another set, and apply it to paired ChIP-seq experiments. We show that, using
paired ChIP-seq data for a single transcription factor, differential motif enrichment analysis identifies all the known key
transcription factors involved in the transformation of non-cancerous immortalized breast cells (MCF10A-ER-Src cells)
into cancer stem cells whereas non-differential motif enrichment analysis does not. We also show that differential
motif enrichment analysis identifies regulatory motifs that are significantly enriched at constrained locations within
the bound promoters, and that these motifs are not identified by non-differential motif enrichment analysis. Our
methodology differs from other approaches in that it leverages both comparative enrichment and positional
enrichment of motifs in ChIP-seq peak regions or in the promoters of genes bound by the transcription factor.
Conclusions: We show that differential motif enrichment analysis of paired ChIP-seq experiments offers biological
insights not available from non-differential analysis. In contrast to previous approaches, our method detects motifs
that are enriched in a constrained region in one set of sequences, but not enriched in the same region in the
comparative set. We have enhanced the web-based CentriMo algorithm to allow it to perform the constrained
differential motif enrichment analysis described in this paper, and CentriMo’s on-line interface (http://meme.ebi.edu.
au) provides dozens of databases of DNA- and RNA-binding motifs from a full range of organisms. All data and output
files presented here are available at http://research.imb.uq.edu.au/t.bailey/supplementary_data/Lesluyes2014.
Keywords: Comparative ChIP-seq analysis, Constrained differential motif enrichment analysis, MCF10A-ER-Src cells,
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Background
Sequencemotifs in DNA and RNAmolecules are key play-
ers in the regulation of gene expression. Proteins and RNA
molecules bind to these motifs in a sequence-specific
way to control transcription and subsequent sequestra-
tion or degradation of messenger RNA (mRNA). High-
throughput sequencing technology has given us access
to genome-wide measurements of mRNA levels (e.g.,
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RNA-seq) as well as protein-DNA (e.g., ChIP-seq) or
protein-RNA (e.g., CLIP-seq) interactions [1]. Advances
in protein-binding microarrays and high-throughput vari-
ants of SELEX have recently been used to produce large
compendia of both DNA [2-4] and RNA motifs [5]. These
two threads of technological advancement provide the
necessary inputs for very productive analyses of the regu-
latory roles of sequence motifs associated with particular
DNA- or RNA-binding molecules.
In this paper we describe a methodology for detecting
sequence motifs that are enriched in one set of sequences
relative to another set. This is called differential motif
© 2014 Lesluyes et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
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enrichment analysis (DMEA), and is a type of motif
enrichment analysis [6]. Motif enrichment analysis differs
from de novomotif discovery in that a set of known, well-
characterized motifs are part of the input to motif enrich-
ment analysis. Motif enrichment analysis has two major
strengths relative to motif discovery. Firstly, because the
motifs come from curated motif databases, the iden-
tities of the biological molecules that bind them are
known. Secondly, restricting attention to the curated set
of motifs increases statistical power, allowing more subtle
motif enrichments to be detected. This latter advantage
is simply a consequence of the huge number of possi-
ble sequence motifs that de novo motif discovery must
consider.
The DMEA approach we describe also takes advan-
tage of positional information, in contrast to other motif
enrichment analysis approaches, such as AME [6], which
measure enrichment over a whole genomic region. For
example, ChIP-seq and CLIP-seq technologies identify
the (approximate) loci where a protein interacts with DNA
or RNA, respectively. The resolution of the loci depends
on the technology and is approximately 50 bp for ChIP-
seq [7]. DMEA can leverage this fact by focusing onmotifs
that are enriched in the central 100 bp portion relative
to the flanks, of genomic regions identified by ChIP-seq.
This is the approach taken by the original CentriMo algo-
rithm [8], and is still available in the enhanced version of
that algorithm that we describe here. A fortunate side-
effect of using positional information in this way is that
the flanking regions provide a built-in negative control for
the statistical test of motif enrichment.
Positional information can also be leveraged by DMEA
when motifs occur at preferred locations anywhere (not
just centrally) within the input sequences. Examples of
where this is useful include promoters for expressed genes
aligned on their start of transcription (TSS) or ChIP-seq
regions aligned on the best match to the known motif of
the binding protein. In the former case, regulatory motifs
frequently occur at preferred locations relative to the TSS
(e.g., the TATA-box around 30 bp upstream of mam-
malian TSSs [9]). In the latter case, co-regulatory proteins
frequently bind in particular configurations [10]. In the
new version of the CentriMo algorithm described here, we
allow the user to relax the requirement that the enriched
region be centrally located. This allows CentriMo to be
applicable in a wider range of scenarios.
The major contribution of this paper is to describe and
illustrate differential local motif enrichment analysis. We
show that DMEA can identify biologically relevant motifs
that are relatively enriched in one set of ChIP-seq peaks
compared to another. Importantly, in the example we
study here, these relevant motifs are not detected with-
out the use of differential analysis. In addition, we apply
differential enrichment analysis to two sets of promoters,
bound or unbound by a particular transcription factor,
and detect a number of motifs for physiologically relevant
motifs. Our analyses are based on published ChIP-seq
data in transformed and untransformed versions of an
immortalized breast cell line, but the approach is com-
pletely general and can yield biological insights in many
experimental settings, as we describe in the Discussion
section.
Results and discussion
Finding differentially enrichedmotifs in paired ChIP-seq
experiments
Differential motif enrichment analysis can be used to ana-
lyze two ChIP-seq experiments for the same TF. One
objective of such an analysis is to determine if the ChIP-
ed TF changes co-factors between the two experiments.
Given two sets of ChIP-seq peak regions for TF X
from experiments A and B, known motifs differentially
enriched in setA relative to set Bmay indicate thatX is co-
regulating some of its targets in conjunction with different
TFs in the two experiments. Hints as to the identities of
the co-factors are provided by the annotation associated
with the known, differentially enriched motifs.
One caveat to this type of analysis is that the observed
differential enrichment of motifs may be an artifact of
the relative efficiency of the two ChIP-seq experiments.
For example, if experiment A was more successful than
B at predicting the actual bound sites of TF X, the peak
regions in set Amay be more enriched for some co-factor
motifs even though those motifs are not truly differen-
tially enriched in the true populations of binding sites of
TF X in the two experiments. It would therefore be incor-
rect to claim that enrichment of a motif in set A relative
to set B was evidence of differential co-factor use. On the
other hand, it would be valid to make this claim for motifs
enriched in set B relative to set A.
Fortunately, it is easy to determine which of two ChIP-
seq experiments for a TF X was more successful using the
enhanced CentriMo algorithm. We simply run CentriMo
and look for differential enrichment of the known DNA-
binding motif for the ChIP-ed TF in set A relative to set
B. If the known DNA-binding motif for the ChIP-ed TF is
significantly differentially enriched (E-value of the Fisher
exact test < 0.05, henceforth the “Fisher E-value”), it is
unsafe to use set B as the control. Conversely, if the Fisher
E-value of the known motif for TF X reported is much
larger than 1, it is safe to use set B as the control. This can
be confirmed by running CentriMo with the roles of sets
A and B swapped.
We performed this analysis on the pairs of ChIP-
seq experiments for tamoxifen-treated and EtOH-treated
(“untreated”) MCF10A-ER-Src (Table 1). Treatment of
these cells with tamoxifen has been shown to lead to
self-renewing mammospheres that contain cancer stem
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Table 1 Relative enrichment of themotif for the ChIP-ed TF
in tamoxifen-treated and untreatedMCF10A-ER-Src cells
Fisher E-value
ChIP A B Motif A vs. B B vs. A
FOS Tam 4 hr EtOH Fos 884 1.24e-87
FOS Tam 12 hr EtOH Fos 884 4.07e-59
FOS Tam 36 hr EtOH Fos 884 1.24e-06
MYC Tam 4 hr EtOH Myc 884 4.95e-05
STAT3 Tam 12 hr EtOH Stat3 884 2.74e-11
STAT3 Tam 36 hr EtOH Stat3 884 1.15e-10
The table columns show the name of the ChIP-ed transcription factor (“ChIP”),
the names of the two ChIP-seq peak region sets (columns “A” and “B”), the name
of the known (JASPAR) motif for the ChIP-ed TF (“Motif”) and the Fisher E-value
(adjusted for 884 knownmotifs) reported by CentriMo when the first-named
peak region set is used as the “treatment” and the second as the “control”.
CentriMo site probability curves for the cases in bold font and the JASPAR IDs of
the knownmotifs are given in Figure 1.
cells [11]. In all these experimental pairs, it happens that
the the known motif for the TF is significantly relatively
enriched in the “untreated” cells. This is apparent from the
highly significant Fisher E-value when the peak regions for
the untreated cells (set B) are used as the “treatment” set
in CentriMo’s input. Conversely, when the treated cell data
(set A) are given as the “treatment” set to CentriMo, the
Fisher E-value is always its maximum possible value (884,
the number of motifs given as input to CentriMo). The
CentriMo site probability curves for the known motif for
three “A vs. B” cases from Table 1 are shown in Figure 1.
The results in Table 1 and Figure 1 make it clear that it is
only safe to make inferences about differentially enriched
motifs in the MCF10A-ER-Src ChIP-seq data if we use
the untreated (EtOH) cells as the control, not vice-versa.
Therefore, in what follows, we use CentriMo only to look
for knownmotifs that are relatively enriched in the centers
of ChIP-seq peak regions from tamoxifen-treated cells
compared with untreated cells.
For each of the three ChIP-ed factors—FOS, MYC and
STAT3—CentriMo differential motif enrichment analy-
sis identifies one or both of the other two factors as
the most significantly enriched known motif after tamox-
ifen treatment (Table 2). The effect sizes (odds ratios,
see Additional file 1: Tables S2–S7) for these six relative
enrichments are large, ranging from 1.18 to 1.41, show-
ing that the enriched motifs for the secondary factors
are at least 18% more likely to occur near the center of
the ChIP-seq peak in the treated cells. For example, with
tamoxifen treatment of 12 or 36 hours, the most rela-
tively enrichedmotif in the FOS ChIP-seq peaks is a STAT
motif, and vice-versa (Table 2, first line). A STAT motif
is also the most differentially enriched in the peaks from
cells treated for 4 hours. In the MYC ChIP-seq experi-
ment, CentriMo reports that the three most differentially
enriched motifs in the treated cell peaks are FOS and
STAT motifs (odds ratios from 1.19 to 1.20). All these
differential motif enrichments are highly significant sta-
tistically (Fisher E-value < 10−7) and suggest that FOS,
MYC and STAT3 begin binding in close proximity to each
other at many genomic loci in MCF10A-ER-Src cells after
treatment with tamoxifen.
This CentriMo differential motif analysis also identifies
motifs for several other TFs with known roles in MCF10A
cells, suggesting that they may be bound by co-factors of
FOS, MYC and STAT3 (Table 2). Possible co-factors that
become more active upon tamoxifen treatment include
ELK1, ATF4, and NF-κB. ELK1 is known to regulate
MCF10A breast epithelial cell migration [12]. The Cent-
riMo site distribution plot for the ELK1 motif and the
logos for it and the other similar motifs (mostly ETS fac-
tors) are shown in Figure 2. ATF4 forms heterodimers
with both FOS and c-Jun [13], two members of the var-
ious AP1 complexes whose roles in MCF10A cells are
now being explored [14]. The role of NF-κB in tamoxifen
treated MCF10A-ER-Src cells is well established. NF-κB
responds to the inflammatory response triggered by the
transient presence of Src and leads to activation of STAT3,
as reported by the group which produced the ChIP-seq
datasets we use in this analysis [11].
Perhaps the most interesting motifs are those that are
enriched in ChIP-seq peaks from tamoxifen-treated cells
but not enriched before treatment. We can easily restrict
the analysis to such motifs using CentriMo’s interactive
HTML output, which allows filtering on various fea-
tures including motif significance in either set of peaks.
The nature of the association of binding by FOS, MYC,
STAT3 and NF-κB becomes clearer when we restrict the
analysis to motifs that are not significantly enriched in
un-treated MCF10A-Er-Src cells (Table 3, see Additional
file 1: Tables S8–S13 for effect sizes). In FOS peaks,
the relative enrichment of NF-κB motifs is not signif-
icant after four hours of tamoxifen treatment (Fisher
E-value = 6.7), but becomes highly significant (Fisher
E-value < 10−8) after 12 hours of treatment. This asso-
ciation between FOS binding and NF-κB motifs then
disappears after 36 hours of treatment. By contrast, NF-
κB motifs are significantly differentially enriched in MYC
ChIP-seq peaks after only four hours of tamoxifen treat-
ment, but they are never differentially enriched in STAT3
peaks after treatment. The analysis presented in Table 3
also shows that CTCF motifs are differentially enriched in
FOS peaks at the same treatment time point (12 hours)
as NF-κB motifs, and not differentially enriched in peaks
for the other two TFs (MYC and STAT3). As in the previ-
ous analysis (presented in Table 2), CentriMo specifically
identifies differential enrichment of motifs in the fam-
ilies of STAT3 and FOS in each others bound regions
after treatment, suggesting that they regulate an overlap-
ping set of targets in tamoxifen treated MCF10A-ER-Src
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Figure 1 The knownmotif for the ChIP-ed motif is more enriched in ChIP-seq peak regions from untreatedMCF10A-ER-Src cells. The
CentriMo plots show the distribution of a known motif for the ChIP-ed TF in FOS, MYC and STAT3 ChIP-seq peak regions (top-to-bottom). Solid
(dotted) curves show the positional distribution of the known motif in the tamoxifen-treated (untreated) cell ChIP-seq peak regions. Tamoxifen
treatment time is 4 hours except in the STAT3 ChIP-seq experiment where it is 12 hours. JASPAR motif names and IDs and the p-value of the motif’s
central enrichment in the treated cell peaks is shown in the legend of each plot.
cells. The new analysis in Table 3 highlights the transient
role of NF-κB in co-regulating the targets of FOS and
MYC.
The benefit of differential motif enrichment analysis in
paired ChIP-seq experiments
As we have seen, the most highly differentially enriched
motifs in the paired ChIP-seq experiments are extremely
relevant to the biology of MCF10A cells. However, if
we look at the central enrichment of the FOS-, MYC-,
STAT- and NF-κB-family motifs in the tamoxifen-treated
cells, rather than at their differential enrichment, they
are not among the most highly enriched. (This is con-
veniently done with CentriMo by choosing to sort by
E-value rather than Fisher E-value using a drop-down
menu in the CentriMo output.) For example, in the
FOS ChIP-seq experiments, all MYC, STAT and NF-
κB motifs rank far down the list of 884 known motifs
in terms of central enrichment (Table 4). Although a
STAT-family motif (STAT1) is the most differentially
enriched motif (Table 2 and Table 3), non-differential
enrichment places all STAT-family motifs at rank 112
or below in the three tamoxifen-treated FOS ChIP-seq
datasets (Table 4). Non-differential motif enrichment
analysis thus does not make clear the important biolog-
ical role of STAT3 in tamoxifen-treated MCF10A-ER-
Src cells. The same is true for the role of NF-κB, as
motifs for NF-κB rank far down the list in the non-
differential enrichment analysis of FOS ChIP-seq peaks
(rank ≥ 282, Table 4), whereas an NF-κB motif is ranked
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Table 2 Relatively enrichedmotifs in tamoxifen-treated vs. untreatedMCF10A-ER-Src cells
FOS
4 hr 12 hr 36 hr
Motif E-value Motif E-value Motif E-value
STAT1 5.7e-22 STAT1 1.6e-24 STAT1 1.5e-17
Stat3 7.2e-18 Stat3 3.3e-21 Stat3 1.4e-05
FLI1_full 1.3e-08 FEV 1.1e-14 ATF4_DBD 2.2e-05
FEV_DBD 1.9e-08 ETS1_DBD 1.1e-13 NFIL3_DBD 7.4e-05
ETV4_DBD 3.1e-08 ELK3_DBD 1.3e-13 HLF_full 0.00015
ELK1_DBD 5.7e-08 FLI1_full 1.4e-13 ETV1_DBD 0.00032
FLI1_DBD 5.8e-08 ERG_DBD 1.6e-13 ETV4_DBD 0.00037
ERG_DBD 8.1e-08 ERG_full 1.6e-13 HLF 0.00048
ELK3_DBD 8.8e-08 ELK1_DBD 2.2e-13 ELK3_DBD 0.00063
ETS1_full 1.1e-07 RELA 3.3e-13 ETV6_full_2 0.0011
MYC STAT3
4 hr 12 hr 36 hr
Motif E-value Motif E-value Motif E-value
Fos 5.7e-17 Fos 1.8e-42 Fos 1.7e-32
AP1 3.4e-16 AP1 9.7e-33 AP1 2.2e-22
STAT1 1.1e-08 JDP2_DBD 1.5e-21 JDP2_full 3.4e-20
Stat3 0.0027 JDP2_full 1.1e-20 JDP2_DBD 1.2e-19
RELA 0.0085 Jdp2_DBD 6.4e-17 Jdp2_DBD 5.3e-18
NF-kappaB 0.0088 NFE2_DBD 3e-14 NFE2_DBD 1.2e-10
NFE2L1::MafG 0.065 NFE2L1::MafG 6.8e-09 NFE2L1::MafG 8e-09
CEBPA 0.11 NFE2L2 9.7e-05 MEOX2_DBD 0.0077
FEV 0.28 MAFF_DBD 0.27 NFE2L2 0.0078
REL 0.49 Pax2 0.3 MEOX1_full 0.097
The table shows the ten most differentially enriched motifs in ChIP-seq peaks for the given ChIP-ed TF (top lines) in MCF10A-ER-Src cells treated with tamoxifen for the
given time (second lines) compared with untreated cells. The name of the JASPAR or Jolma et al. [3] motif and its Fisher E-value as computed by CentriMo are given
and each column in the table is sorted by E-value. Significant (≤ 0.05) E-values are shown in bold font. All enriched motifs have odds ratios at least 1.09.
A B
Figure 2 ELK1 and other ETS-factor motifs are relatively enriched in FOS ChIP-seq peaks from tamoxifen treated MCF10A-ER-Src cells.
Panel A shows the central enrichment of the ELK1_DBD motif (from Jolma et al. [3]) in the treated-cell (solid line) and untreated-cell (dotted line)
FOS ChIP-seq peaks. Treatment was for 4 hours. Panel B shows the logos of the eight most differentially enriched ETS-factor motifs.
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Table 3 Motifs that are not enriched in untreatedMCF10A-ER-Src cells but that are enriched in tamoxifen-treated cells
FOS
4 hr 12 hr 36 hr
Motif E-value Motif E-value Motif E-value
STAT1 5.7e-22 STAT1 1.6e-24 STAT1 1.5e-17
SPI1 0.003 REL 2.7e-09 BSX_DBD 0.8
CTCF 3.1 NF-kappaB 7.4e-09 UNCX_DBD 7.3
NFKB2_DBD 6.7 NFKB2_DBD 2.2e-05 PDX1_DBD_2 8.8
SPIB 27 NFKB1 8.5e-05 Dbp_DBD 17
RXR::RAR_DR5 159 ETS1 0.00057 NKX6-2_full 28
SP1 159 CTCF 0.0065 HNF1A_full 45
INSM1 177 SPIB 0.8 POU6F2_full 48
NFKB1 239 Spic_DBD 177 Dlx2_DBD 50
RARG_full_3 557 SPI1 212 Lhx8_DBD_2 50
MYC STAT3
4 hr 12 hr 36 hr
Motif E-value Motif E-value Motif E-value
STAT1 1.1e-08 AP1 9.7e-33 MEOX2_DBD 0.0077
NF-kappaB 0.0088 Hoxa2_DBD 42 DLX5_FL 0.11
NFKB1 1.2 SPIB_DBD 53 En2_DBD 0.13
NFKB1_DBD 9.7 POU1F1_DBD 239 POU1F1_DBD 0.22
NFKB2_DBD 9.7 VAX2_DBD 265 Meox2_DBD 0.57
EN1_full_2 12 En2_DBD 309 Hoxa2_DBD 0.7
NR2E1_full 15 MZF1_1-4 398 VAX1_DBD 1.6
TEAD1_full 23 ZIC3_full 415 EMX2_DBD 2.4
MEOX2_DBD 33 Nkx6-1_DBD 424 HOXB5_DBD 2.5
MZF1_1-4 36 HMBOX1_DBD 442 EVX2_DBD 4.5
The table shows the most differentially enriched motifs in ChIP-seq peaks in tamoxifen treated cells where the motif is not significantly enriched (E-value≥ 1) in the
untreated MCF10A-ER-Src cells. The first two lines show the ChIP-ed TF and the tamoxifen treatment time, respectively. The name of the JASPAR or Jolma et al. [3]
motif and the significance of its differential enrichment (Fisher E-value) as computed by CentriMo are given and each column in the table is sorted by E-value.
Significant (≤ 0.05) E-values are shown in bold font.
third and fourth in the differential motif enrichment anal-
ysis of cells treated with tamoxifen for 4 hr or 12 hr
(Table 3).
The benefit of differential motif enrichment analysis is
also seen in the MYC and STAT3 ChIP-seq experiments.
Differential analysis of pairedMYCChIP-seq experiments
places FOS, STAT and NF-κB at the top of the list of
884 known motifs (Table 2), but non-differential analy-
sis only highlights FOS motifs (Fos rank=11, Table 4).
In the tamoxifen-treated cell MYC ChIP-seq experiment,
STAT- and NF-κB-family motifs rank below 180 out of
884 motifs. In the case of the STAT3 experiments, both
differential and non-differential enrichment rank FOS
motifs near the top of the list (Table 2 and Table 4), but
differential analysis also ranks an NF-κB motif at posi-
tion 14 in the 12 hr treated cells (NFKB2_DBD, data not
shown).
Non-differential central motif enrichment analysis con-
tinues to be useful for studying the DNA-binding affinity
of the ChIP-ed TF. In all six tamoxifen-treated cell ChIP-
seq experiments, a known motif from the ChIP-ed TF’s
family ranks near the top of the list (Fos, Mycn and
STAT1 motifs in FOS, MYC and STAT3 experiments,
respectively, Table 4). In the three FOS experiments and
the MYC experiment, the JDP2_full motif, which is highly
similar to the Fos motif, ranks first. In the case of the FOS
ChIP-seq peaks, this may indicate that the JDP2_full motif
is may more faithfully represent the DNA-binding affin-
ity of FOS than the JASPAR Fos motif does (Figure 3A).
It is more surprising that the JDP2_full motif is more sig-
nificantly centrally enriched than any MYC-family motif
in the MYC ChIP-seq peaks. However, the enrichment
of the Mycn motif in the MYC peaks is actually more
spatially confined (Figure 3B). The regions of maximal
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Table 4 Central enrichment of STAT, FOS, MYC and NF-κBmotifs in ChIP-seq peaks in tamoxifen-treatedMCF10A-ER-Src
cells
FOS
4 hr 12 hr 36 hr
Motif E-value Motif E-value Motif E-value
JDP2_full 1 JDP2_full 1 JDP2_full 1
Fos 4 Fos 4 Fos 4
Mycn 125 Stat3 112 Mycn 117
Stat3 130 Mycn 122 Stat3 136
NFKB1_DBD 322 NFKB2_DBD 282 NFKB1_DBD 402
MYC STAT3
4 hr 12 hr 36 hr
Motif E-value Motif E-value Motif E-value
JDP2_full 1 STAT1 1 STAT1 1
Mycn 3 Fos 6 Fos 6
Fos 11 NF-kappaB 79 NF-kappaB 110
Stat3 181 Mycn 213 Mycn 221
NFKB2_DBD 317
The table shows the name and rank (out of 884) of the most significantly enriched motif from each of the four TF families in the peaks of the ChIP-ed TF (top lines) in
MCF10A-ER-Src cells treated with tamoxifen for the given time (second lines). The top-ranking motif is also shown even if it is not from one of the four TF families. Rank
is based on the CentriMo (non-differential) central enrichment E-value.
central enrichment for the JDP2_full and Mycn motifs
are 148 bp and 99 bp wide respectively (data not shown).
Thus, despite the lower p-value of the JDP2_full motif, the
non-differential central motif enrichment analysis allows
correct identification of the Mycn motif as most similar to
the primary DNA-binding motif of the ChIP-ed TF, MYC.
Differential local enrichment of motifs in bound and
unbound promoters
CentriMo can be used to perform local motif enrichment
analysis in regions aligned at a genomic landmark such as
the transcription start site (TSS) of each of a set of genes.
Other useful genomic landmarks such as translation start
sites, intron-exon boundaries and polyadenylation sites
can also be used to align genomic regions to be ana-
lyzed by CentriMo. In addition, if two sets of regions are
provided to CentriMo, it can also be used to perform
differential local motif enrichment analysis.
Using the same ChIP-seq data fromMCF10A-ER-Src as
before, we performed differential local motif enrichment
analysis comparing promoter regions near FOS, MYC or
STAT3 binding sites (“bound promoters”) with promoter
regions distal from any binding site (“unbound promot-
ers”). To do this, for each ChIP-seq experiment we split
A B
Figure 3 Top non-differentially enrichedmotifs in ChIP-seq peak regions from tamoxifen-treated MCF10A-ER-Src cells. The CentriMo plots
show the distribution of the given motifs in the (A) FOS and (B)MYC ChIP-seq peak regions from MCF10A-ER-Src cells after 4 hr treatment with
tamoxifen. The motif names and IDs and the p-value of the motif’s central enrichment in the ChIP-seq peaks is shown in the legend of each plot,
and the motif logos are shown below the legend.
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the annotated human TSSs (hg19, UCSC Genes) into two
sets depending on whether they were within 1000 bp of a
declared ChIP-seq peak or not.We then created two input
files containing the 500 bp regions centered on the TSSs
of these promoters and used them as input CentriMo. We
will refer to the first set as “FOS-bound” promoters and
the second as “FOS-unbound” promoters, etc.
In untreated MCF10A-ER-Src cells the motifs for FOS,
MYC and STAT3 are not the most locally enriched motifs
in the 500 bp regions centered on TSSs near ChIP-seq
peaks for the respective transcription factors (Table 5). In
terms of local enrichment, the highest rank for a motif
from the ChIP-ed TF’s family is 125 (out of 884, STAT3).
On the other hand, motifs from the ChIP-ed TFs fam-
ily show strong differential local motif enrichment when
comparing bound and unbound promoters. Notably, a
motif for STAT3 ranks first in terms of differential local
enrichment in bound vs. unbound promoter regions
(Table 5), compared with a best rank of 125 in terms of
local motif enrichment in bound promoter regions.Motifs
from the FOS and MYC families also have significantly
higher ranks (Fos: 11 vs. 288 and Myc/Mycn: 63 vs 365) in
promoters bound by FOS and MYC, respectively.
We note also that the motif for NF-YA (JASPAR motif
NFYA) is highly differentially enriched enrichment in pro-
moters bound by MYC (Table 5, rank 1, Fisher E-value<
10−38), but less so in promoters bound by FOS (rank 24,
Fisher E-value 0.01, data not shown). Recent work in dif-
ferent cell lines (K562, GM12878, HeLa S3) indicated an
association between MYC and NF-Y at promoters, and a
strong association between NF-Y and FOS at loci lacking
the AP-1 motif [15].
Selecting the individual motifs for display in the
CentriMo interactive report for FOS bound/unbound
promoters shows the JASPAR AP1 motif is present in
34% of the bound promoters, and the JASPAR NFYA
motif in 22%. Choosing both motifs for display causes
CentriMo to report the intersection size as well—8%—
which is barely above what would be expected by chance
if the presence of the two motifs were uncorrelated
(34% · 22% = 7.48%).
Thus, CentriMo reveals that motifs for NF-Y and AP-1
do not seem to be associated at FOS-bound promoters in
MCF10A-ER-Src cells, as was previously shown in other
cell lines [15].
The CentriMo analysis of the local differential motif
enrichment in the FOS ChIP-seq dataset is particularly
interesting (Figure 4). The most differentially enriched
motif in bound vs. unbound promoters is JDP2_DBD,
a cAMP response-element (CRE) motif for the DNA-
binding domain (DBD) of the Jun dimerization protein2
(JDP2). This motif is essentially the same as that of other
FOS family members, The differential local enrichment
of this motif is highly significant (Fisher E-value < 10−9,
Figure 4A), but it is not locally enriched in the unbound
promoters (E-value = 884). However, JDP2 can also bind
a TPA-response element (TRE), and this motif ranks
third in terms of local enrichment (Figure 4B), but is
not significantly differentially enriched according to the
CentriMo analysis (Fisher E-value = 3.1). As seen in the
logos in Figure 4, the TRE and CRE motifs differ only
in the distance between the palindromic ATGA/TCAT
half-sites. The CentriMo analysis thus reveals that all
human promoters are locally enriched for TRE motifs,
but FOS-bound promoters in MCF10A-ER-Src cells are
relatively enriched for the closely related CRE motif typ-
ical of FOS binding in the 100 bp region upstream of
the TSS.
Local differential motif enrichment analysis of FOS-
bound and unbound promoters also highlights several
Table 5 Local motif enrichment in bound and unbound promoters in untreatedMCF10A-ER-Src cells
FOS MYC STAT3
Motif Rank Motif Rank Motif Rank
Local Enrichment: Proximal TSSs
SP4_full 1 SP4_full 1 KLF14_DBD 1
Fos 288 Mycn 365 STAT1 125
Mycn 323 STAT1 482 Mycn 505
STAT1 874 Fos 587 Fos 541
Differential Enrichment: Proximal vs. Distal TSSs
JDP2_DBD 1 NFYA 1 Stat3 1
Fos 11 Myc 63 MYC::MAX 795
Mycn 33 Fos 532 Fos 829
STAT1 857 STAT1 559
The table summarizes local motif enrichment around TSSs proximal (within 1000 bp) or distal to the nearest peak in FOS, MYC and STAT3 ChIP-seq experiments in
untreatedMCF10A-ER-Src cells. For each ChIP-ed factor, we report the name (in the JASPAR+Jolma compendium) and rank (out of 884) of the most significantly
enriched motif from each of the three ChIP-ed TF families. in untreatedMCF10A-ER-Src cells. Rank is based on either the local enrichment in bound promoters
(“Proximal TSSs”) or the differential local enrichment between bound and unbound promoters (“Proximal vs. Distal TSSs”). The top-ranking motif is also shown even if
it is not from on of the three ChIP-ed TF families. The numbers of proximal (distal) TSSs are FOS: 4503 (44548); MYC: 11192 (37859); and STAT3: 2261 (46790).
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A B
Figure 4 TRE and CREmotifs near promoters bound by FOS in untreatedMCF10A-ER-Src cells. The CentriMo plots show the distribution of a
known motif for the ChIP-ed TF around TSSs that are near (≤ 1000 bp) a FOS ChIP-seq peaks (solid curve) or more distal (dotted curve). The plots are
centered on the TSS. Panel A shows the motif (a CRE motif) with most significant differential local enrichment (Fisher E-value = 1.4 · 10−10); panel
B shows the third most locally enriched motif (a TRE motif) around FOS-bound promoters (non-differential E-value = 1.4 · 10−52. Motif IDs and the
p-value of the motif’s local enrichment near the FOS-bound promoters is shown in the legend of each plot.
motifs that may be of interest in the study of breast cancer.
When we sort the CentriMo output by differential enrich-
ment (Fisher E-value, Figure 5), among the top twelve
motifs are seven motifs similar to the Fos-family consen-
sus (TGANTCA), including the first five motifs. A search
of the literature reveals that three of the five remaining
motifs belong to proteins with possible links to breast
cancer: include Srebf1_DBD, Arnt and DBP_full. Srebp1
(sterol regulatory element-binding protein-1), also known
as Srebf1, may be involved in breast cancer stem-like cell
survival [16], as was shown usingMCF10A andMCF10AT
cells [16]. Lipogenesis, of which Srebp1 is a master reg-
ulator, may play a critical role in early breast carcino-
genesis, and increased expression of lipogenic enzymes
seems to correlate with increased risk of development of
breast cancer [17]. Arnt has been shown to have a role
in estrogen receptor-negative breast cancer [18]. A role
in the regulation of BRCA2 has been demonstrated for
DBP (vitamin D-binding protein) [19]. We did not find
any known link to breast cancer for the remaining two
motifs, ATF4_DBD and BHLHB2_DBD. The high pro-
portion of biologically interesting motifs among the most
significant differentially enriched motifs in FOS-bound
promoters demonstrates the potential value of this use of
CentriMo.
Conclusions
We have shown that differential local motif enrichment
analysis can yield insights beyond those available from
motif analysis of a single dataset. Using this new feature
of the CentriMo algorithm, we showed that the differen-
tial analysis of ChIP-seq peaks for a single transcription
factor under two different cellular conditions identifies
several other transcription factors with pivotal roles in the
Figure 5 Local differential enrichment of motifs in FOS-bound vs. unbound promoters. A (partial) screenshot of the CentriMo interactive
output using FOS-bound and unbound promoters shows the twelve most locally differentially enriched motifs in the JASPAR+Jolma compendium.
For each motif, the table shows its ID and name in the compendium, the local enrichment in the bound promoters (“E-value”), the differential
enrichment (“Fisher E-value”) in the bound vs. unbound promoters, the (unadjusted) significance of the local enrichment in the bound promoters
(“p-value”), the (unadjusted) significance of the local enrichment in the unbound promoters (“Negative p-value”), and the coordinates of the region
of maximum enrichment in the bound promoters (“Region center” and “Region width”).
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distinguishing the two cellular states. In particular, Cent-
riMo differential analysis of ChIP-seq of just FOS in trans-
formed and untransformed MCF10A-ER-Src cells ranks
motifs from the STAT andNF-κB families first and second
in terms of statistical significance (Table 3, FOS 12 hr col-
umn), whereas non-differential analysis ranks them 112
and 282 out of 884 motifs (Table 4). Given that STAT3
and NF-κB have been shown to be the key transcrip-
tion factors in the positive feedback loop that maintains
the transformed state of MCF10A-ER-Src after removal of
the tamoxifen stimulus [11], this result shows the poten-
tial of differential local motif analysis of paired ChIP-seq
experiments to identify important candidate transcription
factors for further investigation.
We have also demonstrated the utility of differential
local motif analysis is also useful for analyzing signals
near genomic landmarks such as TSSs. One such appli-
cation is the comparative motif analysis of promoters
bound our unbound by a particular transcription fac-
tor. Using some of the same ChIP-seq data for FOS as
above, CentriMo differential local motif analysis revealed
the a probable association between binding of FOS and
a MYC family member, most likely MYC at promoters in
MCF10A-ER-Src cells. The same analysis also highlighted
the widespread presence of TREmotifs in human promot-
ers and the lack of the related (one extra base-pair) CRE
motif in promoters not bound by FOS inMCF10A-ER-Src
cells.
One can imagine many other scenarios where differ-
ential motif analysis would be useful. We studied paired
ChIP-seq experiments before and after a treatment. The
same types of analysis could be applied to pairs of ChIP-
seq experiments from different cell or tissue types, or
from the same tissue at different developmental stages.
CentriMo could also be used with RNA-binding protein
(RBP) motifs to study paired CLIP-seq (or equivalent)
datasets. The CentriMo website currently provides one
large compendium of RBP motifs [5] and users can also
upload their own sets of motifs. Our local motif enrich-
ment analysis focused on promoters near to or distal from
ChIP-seq peaks, but one could also examine sets of pro-
moters grouped using other criteria (e.g., expressed vs.
not expressed in a given tissue). In short, differential motif
analysis can be applied whenever paired sets of genomic
regions or RNA molecules may harbor encoded signals,
regulatory or otherwise.
A single CentriMo differential motif enrichment anal-
ysis can be used in many different ways. The CentriMo
report is highly interactive and allows the user to sort the
results by non-differential enrichment, differential enrich-
ment, position of enrichment, number of motif matches,
andmany other criteria. The user can also filter the results
by non-differential or differential enrichment significance,
the size of the enriched region or enrichment in the
control dataset. The user also has full control over what
information to display via check boxes on the report. The
positional distribution of motif matches of user-chosen
motifs is plotted and can be panned and zoomed interac-
tively, and the plot can be in terms of either match posi-
tion or distance from the sequence center. The CentriMo
report also provides for creation of publication quality
figures from the distribution plots.
The value of all forms of motif enrichment analysis,
including the differential local analysis presented here,
depends to a large extent on the availability of high-
quality, annotated motif databases. Fortunately a large
and growing number of such databases are now available
for both transcription factors and RNA-binding proteins.
These databases, which are made available for use with
CentriMo via its website, are based on a number of tech-
nologies including ChIP-seq, high-throughput SELEX,
and protein binding microarrays. The complementary
strengths and weaknesses of these different experimental
technologies makes it advisable to repeat motif enrich-
ment analyses using motif databases based on different
technologies.
Among the databases made available by the Cent-
riMo website are DNA-binding motif databases, including
comprehensive databases of vertebrate motifs, special-
ized databases for particular organisms, and RNA-binding
motif databases. For vertebrate ChIP-seq data, the com-
prehensive databases (e.g., “All Vertebrates”) will be the
most useful since they contain the largest spectrum of
known motifs. For data from non-vertebrate organisms,
using the most relevant JASPAR specialized database (e.g.,
“JASPAR CORE (2014) fungi”) may be appropriate. Users
may also input custom databases of motifs.
Methods
The CentriMo algorithm
CentriMo is a web-based visualization and statistical anal-
ysis tool for performing several types of motif enrichment
analysis using one or two sets of equal-length DNA or
RNA regions and sets of annotated motifs. It is partly
based on an earlier, much simpler algorithm with the
same name [8], but has vastly greater capabilities. While
the original algorithm could only detect motifs enriched
in the centers of a single set of sequences using a fixed
motif-score threshold, CentriMo finds motifs enriched
in any sub-region of the sequences and measures their
relative enrichment in a comparative set of sequences,
as well as automatically finding the optimal motif-score
threshold. Unlike the earlier algorithm, CentriMo features
interactive output for plotting the positional distribu-
tion of one or more of the significantly enriched motifs,
displays the motif logos and allows the user to create cus-
tom publication-quality images of the plots. The user can
also choose which motifs to display and view the sizes
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of the intersection and union sets of sequences contain-
ing the motif in the sub-region of enrichment. The user
can also extract the sequence identifiers of the set of
sequences that contain all of the chosen, enriched motifs.
The CentriMo output also allows the user to sort and fil-
ter the results by motif enrichment in the primary set
of sequences, differential enrichment, location or size of
the constrained sub-region of enrichment of each motif,
or by one of a large number of other characteristics of
the data.
The CentriMo user provides one or two sets of DNA
or RNAsequences, and selects (or provides) a set of DNA
or RNA motifs in position weight matrix (PWM) for-
mat. CentriMo scores [20] each sequence in both the
primary and control datasets using the PWM for a given
motif, storing the position of the best match. By default
CentriMo ignores sequences without a match above a
user-defined score threshold, but it can also choose the
threshold individually for each motif in order to max-
imize its statistical significance in the primary dataset.
The locations of the best matches to the motif in the pri-
mary dataset are then subjected to a statistical analysis
to determine local sub-regions of enrichment. A second,
differential statistical analysis is then applied using both
the primary and control sequence datasets to determine
the relative enrichment of the motif in each of these
sub-regions of local enrichment.
The statistical analysis of local motif enrichment per-
formed by CentriMo is based on the binomial test. The
“enrichment p-value” of a sub-region is the probability
that the number of best matches to the motif falling in the
sub-region would be at least as large as observed given a
uniform prior. In other words, ifM and N are the number
of possible starting positions for the motif in the sub-
region and in a whole single sequence, respectively, the
uniform prior suggests that a random best site would fall
in the sub-region with probability r = MN . CentriMo uses
this r as the probability of a success in a single Bernoulli
trial. If there are s best matches in the sub-region and
S sequences (with best matches), the enrichment p-value
is the probability of ≥ s successes in S trials each with
probability of success r.
Enrichment p-values are adjusted for multiple tests
before being reported by CentriMo. Under the conser-
vative assumption that sub-regions are independent, the
probability that at least one sub-region out of n has
p-value ≤ p′ is p = 1− (1− p′)n. CentriMo reports p, the
“adjusted p-value” of the motif, as well as its E − value—
the expected number of motifs with adjusted p-value ≤ p.
The E-value is computed by multiplying p by the number
of input motifs.
The original CentriMo algorithm limited its con-
sideration to centered sub-regions in the equal-sized
sequences (hence the name of the old algorithm).
CentriMo now can test all possible sub-regions for
enrichment. This increases the number of multiple tests
performed, which reduces the significance level reported
after p-value adjustment. However, when a motif ’s sub-
region of enrichment is not symmetrical around the
centers of the sequence (e.g., when analyzing promot-
ers), the new “local enrichment” mode of CentriMo can
be more sensitive than the default “central enrichment”
mode. Because CentriMo tests sub-regions of all pos-
sible widths and placements in local enrichment mode,
its time complexity increases to quadratic in sequence
length compared, with linear time complexity in central
enrichment mode.
A single motif may be significantly enriched in multiple
sub-regions. To avoid redundancy in its output, CentriMo
uses a greedy strategy ensure that only non-overlapping
significant sub-regions are reported. To do this, it sorts
significant sub-regions by increasing enrichment p-value
and outputs each sub-region in turn as long as it does
not overlap an already-reported sub-region for the given
motif. To maintain compatibility with the original algo-
rithm, the user may limit the CentriMo search to central
sub-regions only, in which case CentriMo reports the
single sub-region with the most significant enrichment
p-value for each motif.
CentriMo’s approach to differential local motif enrich-
ment analysis only reports sub-regions where the motif
is significantly enriched in the primary set of sequences.
Once all the significant sub-regions in the primary
sequences have been determined for a given motif, Cent-
riMo then applies the Fisher exact test [21] to each
sub-region to determine the significance of the rela-
tive enrichment of the motif in that region in the pri-
mary and control sequence sets. The test is computed
on the 2×2 contingency table with rows labeled “suc-
cess/failure” and columns labeled “primary/control”. The
entries in the table are the number best matches in the
sub-region (“success”) or outside the sub-region (“fail-
ure”) in the two sets of input sequences, respectively.
The p-value of the test is the sum of the probabil-
ity of all the 2×2 contingency tables with hyperge-
ometric probabilities at least as small as that of the
observed table. CentriMo adjusts the p-values for multi-
ple tests (sub-regions) as described above, and also reports
the “Fisher E-value” computed as the product of the
adjusted Fisher p-value and the number of motifs in the
CentriMo’s input.
We also considered other approaches to differential
motif enrichment analysis, such as the obvious one of
choosing the region that optimizes the Fisher exact test
on the numbers of best matches in the region in the
two sets of sequences. However, these approaches tended
to identify extremely narrow sub-regions of enrichment
that had no apparent biological interpretation (data not
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Table 6 MCF10A-ER-Src ChIP-seq data files
TF Treatment File name
FOS
36 hr EtOH wgEncodeAwgTfbsSydhMcf10aesCfosEtoh01HvdUniPk.narrowPeak.gz
4 hr tamoxifen wgEncodeAwgTfbsSydhMcf10aesCfosTam14hHvdUniPk.narrowPeak.gz
12 hr tamoxifen wgEncodeAwgTfbsSydhMcf10aesCfosTam112hHvdUniPk.narrowPeak.gz
36 hr tamoxifen wgEncodeAwgTfbsSydhMcf10aesCfosTamHvdUniPk.narrowPeak.gz
MYC
36 hr EtOH wgEncodeAwgTfbsSydhMcf10aesCmycEtoh01HvdUniPk.narrowPeak.gz
4 hr tamoxifen wgEncodeAwgTfbsSydhMcf10aesCmycTam14hHvdUniPk.narrowPeak.gz
STAT3
36 hr EtOH wgEncodeAwgTfbsSydhMcf10aesStat3Etoh01UniPk.narrowPeak.gz
12 hr tamoxifen wgEncodeAwgTfbsSydhMcf10aesStat3Tam112hHvdUniPk.narrowPeak.gz
36 hr tamoxifen wgEncodeAwgTfbsSydhMcf10aesStat3TamUniPk.narrowPeak.gz
The table shows the name of the file (“File Name”) on the UCSC ENCODE website (http://genome.ucsc.edu/ENCODE) containing the ChIP-seq peaks for the given
transcription factor (“TF”) assayed in MCF10A-ER-Src cells after treatment with 0.01% ethanol or 1 μm tamoxifen for the stated time (“Treatment”).
shown). In addition, these alternative approaches are far
more computationally expensive.
Data
All our motif enrichment analyses are based on ChIP-seq
peaks from tamoxifen-treated and untreated MCF10A-
ER-Src cells produced by the Struhl lab at Harvard Uni-
versity [1]. The data includes ChIP-seq experiments using
antibodies against FOS, STAT3 and c-Myc. We down-
loaded this data in narrowPeak format from the UCSC
Genome browser ENCODE website (http://genome.ucsc.
edu/ENCODE). The datasets we use were created by the
ENCODE Analysis Working Group (AWG) using a uni-
form analysis pipeline. The filenames of the datasets are
given in Table 6.
For our paired ChIP-seq experiment analyses we created
genomic sequence sets corresponding to the ChIP-seq
regions by extracting the 500 bp region around the cen-
ter of each ChIP-seq region specified in a narrowPeak file
in Table 6. We followed the sequence extraction protocol
described in [22]. The genomic regions are from UCSC
human genome assembly hg19 and are repeat-masked. For
our promoter analyses, we used the set of human (hg19)
transcription start sites denoted “UCSC Genes” available
via the UCSC Genome Table Browser (http://genome.
ucsc.edu/cgi-bin/hgTables).
For all our motif enrichment analyses we used a com-
pendium of 884 motifs (“JASPAR+Jolma compendium”)
that we created by combining all vertebrate motifs
from JASPAR [23] with all the SELEX-based motifs
from [3]. These two sets of motifs are available on
the MEME Suite website in the MEME motif format
required by CentriMo (http://meme.ebi.edu.au/meme/
meme-download.html).
Motif ranks
To find the highest-ranking FOS-, STAT-, MYC- or NF-
κB-family motifs in CentriMo output we searched the
centrimo.txt output file for the most significant motif
whose name contained the letters ‘fos’, ‘stat’, ‘myc’ or
‘kappa’, respectively. Significance was based on the log-
adjusted p-value of the motif in the positive dataset
(column 6 in centrimo.txt).
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